FDA
approval
· 2014-09-10
FDA Approved: CONTRAVE EXTENDED-RELEASE — Original Application (Nalpropion Pharmaceuticals LLC)
Summary
FDA approved CONTRAVE EXTENDED-RELEASE (naltrexone hydrochloride and bupropion hydrochloride) under an original application for chronic weight management in adu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for CONTRAVE EXTENDED-RELEASE (NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE)